PLIANT THERAPEUTICS INC (PLRX) Stock Cash Flow
NASDAQ:PLRX - Nasdaq - US7291391057 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -201.68M | -161.34M | -123.32M | -97.26M | -41.53M | |||
| Depreciation Amortization | 2.13M | 1.84M | 1.82M | 1.54M | 1.31M | |||
| Change In Working Capital | 17.88M | 1.25M | 4.22M | 6.92M | -1.21M | |||
| Interest Paid | 2.14M | 1.15M | 620.00K | N/A | N/A | |||
| Other non cash items | 48.73M | 41.88M | 22.65M | 13.37M | 4.16M | |||
| OPERATING CASH FLOW | -132.94M | -116.36M | -94.63M | -75.44M | -37.27M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -3.70M | -921.00K | -1.76M | -1.95M | -1.53M | |||
| Other Investing Activity | 136.83M | -126.09M | -148.44M | 75.65M | -209.33M | |||
| INVESTING CASH FLOW | 133.13M | -127.01M | -150.20M | 73.70M | -210.87M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 19.91M | 0.00 | 9.85M | N/A | N/A | |||
| Stock Issued/Repurchased | 3.34M | 275.25M | 217.56M | 2.98M | 213.21M | |||
| Other Financing Activity | -17.00K | -847.00K | -560.00K | -460.00K | 0.00 | |||
| FINANCING CASH FLOW | 23.23M | 274.40M | 226.85M | 2.53M | 213.21M | |||
| CHANGE IN CASH | 23.41M | 31.03M | -17.98M | 790.00K | -34.93M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -132.94M | -116.36M | -94.63M | -75.44M | -37.27M | |||
| Capital Expenditure | -3.70M | -921.00K | -1.76M | -1.95M | -1.53M | |||
| FREE CASH FLOW | -136.64M | -117.28M | -96.39M | -77.39M | -38.80M | |||
All data in USD